Management of second trimester abortion beyond 20 weeks in a tertiary care setting

Reetu Yadav; Reena Rani; Rachna Sharma; K. Rini

doi:10.18203/2320-1770.ijrcog20251564

Authors

Reetu Yadav Department of Obstetrics and Gynecology, ABVIMS & Dr RML Hospital, Delhi, India
Reena Rani Department of Obstetrics and Gynecology, Maulana Azad Medical college, Delhi, India
Rachna Sharma Department of Obstetrics and Gynecology, Maulana Azad Medical college, Delhi, India
K. Rini Department of Obstetrics and Gynecology, Maulana Azad Medical college, Delhi, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20251564

Keywords:

Mid trimester abortion, Medical termination of pregnancy, Second trimester abortion

Abstract

Background: Management of second-trimester abortion beyond 20 weeks is still unclear. To analyse the management of second-trimester abortions in a tertiary care setting.

Methods: A retrospective analysis was carried out over 1 year for the women undergoing 2nd trimester abortion after 20 weeks. The primary outcome was to find out the various regimens used for 2nd-trimester abortion. The secondary outcomes were the number of doses of drug required for completion of the abortion process, complications and side effects associated with the same. Other outcomes like the cause of abortion requirement beyond 20 weeks and the demographic profile of women have been noted. A review of literature was carried out on the management of 2nd trimester abortion beyond 20 weeks.

Results: A total of 57 medical termination of pregnancy (MTP) were carried out. Mifepristone followed by misoprostol was the method of choice in 93% of cases. Other methods adopted were foleys induction, mifepristone alone. The mean number of misoprostol doses used in termination between 20-24 weeks were 3-4 (400 mcg), While it was 4-5 doses (200mcg) beyond 24 weeks of gestation. Hysterotomy and hysterectomy were done as a result of complication arising out of the regimen followed in less than 1 % of cases.

Conclusions: The combination of 200 mg mifepristone and vaginally administered misoprostol is a safe, effective and non-invasive regimen for termination of pregnancy even beyond 20 weeks.

Metrics

Metrics Loading ...

References

Lalit kumar S, Bygdeman M, Gemzell-Danielsoson k. Mid trimester induced abortion:a review. Hum Reprod. 2007;13(1):37-52.

Kumari S, Kishore J. Medical termination of pregnancy (Amendment Bill, 2021): Is it enough for Indian women regarding comprehensive abortion care. Indian J Comm Med. 2021;46(3):367-9. DOI: https://doi.org/10.4103/ijcm.IJCM_468_20

Hammond C. Recent advances in second-trimester abortion: an evidence- based review. Am J Obstet Gynecol. 2009;200(4):347-56. DOI: https://doi.org/10.1016/j.ajog.2008.11.016

Ashok PW, Templeton A, Wagaarachchi PT, Flett GM. Mid trimester medical termination of pregnancy: a review of 1002 consecutive cases. Contracep. 2004;69(1)51-8. DOI: https://doi.org/10.1016/j.contraception.2003.09.006

Morris JL, Winikoff B, Dabash R, Weeks A, Faundes A, Gemzell‐Danielsson K, Kapp N, Castleman L, Kim C, Ho PC, Visser GH. FIGO’s updated recommendations for misoprostol used alone in gynecology and obstetrics. 2017. DOI: https://doi.org/10.1002/ijgo.12181

Nagaria T, Sirmor N. Misoprostol vs mifepristone and misoprostol in second trimester abortion of pregnancy. J Obstet Gynaecol. 2011;61(6):659-62 DOI: https://doi.org/10.1007/s13224-011-0118-4

Dalvie SS. Second Trimester Abortions in India, Reprod Health Matters. 2008;16(31):37-45. DOI: https://doi.org/10.1016/S0968-8080(08)31384-6

Jatlaoui TC, Boutot ME, Mandel MG, Whiteman MK, Ti A, Petersen E.et al. Abortion Surveillance-United States, 2015.MMWR Surveill Summ. 2018;67:1-45. DOI: https://doi.org/10.15585/mmwr.ss6713a1

Adler AJ, Filippi V, Thomas SL. Quantifying the global burden of morbidity due to unsafe abortion: magnitude in hospital-based studies and methodological issues. Int J Gynecol Obstet. 2012;118(2):65–77. DOI: https://doi.org/10.1016/S0020-7292(12)60003-4

Gemzell-Danielsson K, Lalitkumar S. Second trimester medical abortion with mifepristone-misoprostol and misoprostol alone: a review of methods and management. Reprod Health Matters. 2008;16(31):162-72. DOI: https://doi.org/10.1016/S0968-8080(08)31371-8

Hamoda H, Ashok PW, Flett gm, Templeton A. A randomizes trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion at 13-20 weeks. Hum Reprod. 2005;20(8):2348-54. DOI: https://doi.org/10.1093/humrep/dei037

Lalitkumar S, Bygdeman M, Gemzell-Danielsson K. Mid-trimester induced abortion: a review. Hum Reprod. 2007;13(1):37-52. DOI: https://doi.org/10.1093/humupd/dml049

Ho PC, Nagi SW, Liu KL, Wong GC and Lee Sw. Vaginal Misoprostol compared with oral Misoprostol in termination of second trimester pregnancy. Obstet Gynecol. 1997;90:735-8. DOI: https://doi.org/10.1016/S0029-7844(97)00419-5

Ngai SW, Tang OS and Ho PC. Randomised comparison of vaginal (200 mcg every 3 hourly) and oral (400 mcg every 3 hourly) Misoprostol when combined with mifepristone in termination of second trimester pregnancy. Hum Rep. 200;15:2205-8. DOI: https://doi.org/10.1093/humrep/15.10.2205

Tang OS, Chan CC, Kan AS and Ho PC. A prospective randomised comparison of sub-lingual and oral Misoprostol when combined with mifepristone for medical abortion at 12-20 weeks gestation. Hum Rep. 2005;20:3062-66. DOI: https://doi.org/10.1093/humrep/dei196

El- Refaey H and Templeton A. Induction of abortion in the second trimester by a combination of Misoprostol and mifepristone: a randomized comparison between two Misoprostol regimens. Hum Reprod. 1995;10:475-8. DOI: https://doi.org/10.1093/oxfordjournals.humrep.a135965

Agarwal N, Gandhi G, Batra S, Sharma R. Evaluation of mifepristone and Misoprostol for medical termination of pregnancy between 13-20 weeks of gestation. Indian J Clin Prac. 2014;24(9):859-62.

Gupta N, Mittal S. Is mifepristone needed for second trimester termination of pregnancy. J Turkish – German Gynecol Assoc. 2007;8(1):58-62.

Chen M, Shih Jc, Chiu WT, Hsieh FJ. Separation of caesarean scar during second trimester intravaginal Misoprostol abortion. Obstet Gynaecol. 1999;94:840. DOI: https://doi.org/10.1097/00006250-199911001-00018

Berghahn L Christensen D and Droste S. Uterine rupture during second trimester abortion associated with Misoprostol. Obstet Gynaecol. 2001;98:976-7. DOI: https://doi.org/10.1016/S0029-7844(01)01546-0

Dickinson JE. Misoprostol for second trimester pregnancy termination in women with prior caesarean delivery. Obstet Gynaecol. 2005;105:352-56. DOI: https://doi.org/10.1097/01.AOG.0000151996.16422.88

Herabutya Y, Chanarachakul B and Punyavachira P. Induction of labour with vaginal Misoprostol for second trimester termination of pregnancy in the scarred uterus. Int J Gynaecol Obstet. 2003;83:293-97. DOI: https://doi.org/10.1016/S0020-7292(03)00312-6